FOLD SG&A Expense Growth
Amicus Therapeutics Inc · SG&A Expense Growth
FOLD SG&A Expense Growth
Latest reported18.59%period ending
FOLD FY SG&A Growth (YoY) (0.00% → 18.59%)
Latest values, visible window
High-resolution chart · PNG
FOLD sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 18.5875% | |
| 17.477% | |
| 29.2099% | |
| 10.55% | |
| 23.2106% | |
| -7.9206% | |
| 33.5385% | |
| 43.4516% | |
| 24.6237% | |
| 50.5236% | |
| 128.1653% | |
| 9.6544% | |
| -2.4323% | |
| -2.5956% | |
| 26.9476% | |
| -21.5942% | |
| 1.5611% | |
| 28.721% | |
| 24.4486% | |
| 78.5192% | |
| 0% | |
| 0% | |
| 0% |